Literature DB >> 28139473

Association between polymorphisms in the human serotonin transporter gene and lifelong premature ejaculation in the Han population.

Dang-Wei Peng1, Jing-Jing Gao1, Yuan-Yuan Huang1, Dong-Dong Tang1, Pan Gao1, Chao Li1, Wei-Qun Liu1, Xian-Ming Dou1, Jun Mao1, Yao Zhang1, Hao Geng1, Xian-Sheng Zhang1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28139473      PMCID: PMC5753546          DOI: 10.4103/1008-682X.194817

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


× No keyword cloud information.
Dear Editor, Lifelong premature ejaculation (LPE) is a type of sexual dysfunction in males and has three characteristics: (1) an intravaginal ejaculatory latency time (IELT) of ≤1 min; (2) insufficient control over delaying ejaculation; and (3) negative personal consequences, such as distress, frustration, and/or the avoidance of sexual intimacy.1 Its etiologies involve the 5-hydroxytryptamine (5-HT) system. The use of 5-HT transporter (5-HTT) blockers (e.g., selective serotonin reuptake inhibitors, SSRIs) was found to prevent the reuptake of 5-HT from the synaptic cleft into the presynaptic serotonergic neurons, which leads to increased extracellular 5-HT levels, thereby delaying ejaculation.2 The 5-HTT gene (SLC6A4) on human chromosome 17 thus became a candidate target gene for treating LPE and had been isolated and characterized. All of the gene's exons and the adjacent intronic sequences, as well as a tandem repeat DNA polymorphism within the SLC6A4 gene, have been sequenced.3 Polymorphisms in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and in the second intron (STin2) have been studied in LPE, but the findings were inconsistent.45 Other polymorphisms (e.g., single-nucleotide polymorphisms) in this gene have been widely studied in patients with psychosis67 but not in patients with LPE. In the present study, our team explored the association with LPE of single-nucleotide polymorphisms (SNPs) in the 3’ untranslated region (UTR) and 5’ UTR, and of single-nucleotide variants (SNVs) in all exons of SLC6A4. We enrolled 101 men diagnosed with LPE from our outpatient clinics and 99 age-matched healthy controls from the health examination center. All subjects were genotyped for polymorphisms in the 3’ UTR, 5’ UTR and all exons of SLC6A4. For SLC6A4, both the LPE group and the control group showed no significant deviation (P > 0.05) from the Hardy-Weinberg equilibrium (HWE). The SNPs including rs25533, rs6354, rs7224199, rs8066731, and rs1042173 (www.ncbi.nlm.nih.gov/snp/) were identified and analyzed in this study, and the minor allele frequency of these SNPs in the sample population was 11.8%, 12.6%, 18.2%, 18.3%, and 18.1%, respectively. We did not find significant differences between the LPE patients and the controls (P > 0.05). Across all exons, several SNVs were located and analyzed (). Still, no significant differences were found between the LPE group and the control group (P > 0.05). We also assessed linkage disequilibrium (LD) between polymorphisms and found that the SNPs rs8066731, rs7224199, and rs1042173 in the 3’ UTR were located in the observed LD block. Haplotype association analyses for the block, with respect to LPE, were performed with HAPLOVIEW (version 4.1, Broad Institute of Harvard and MIT, Cambridge, MA, USA). The results showed no significant haplotype association with LPE (P > 0.05). SNVs in all exons in LPE patients and controls LPE is a complex sexual dysfunction involving the 5-HT system. Multiple, well-controlled evidence-based studies have demonstrated the efficacy and safety of SSRIs for delaying ejaculation, thus confirming their role as first-line agents for the treatment of LPE and acquired premature ejaculation (APE).8 Medications for SSRI-associated sexual side effects inhibit 5-HTT and increase the synaptic latency period of 5-HT molecules, thereby facilitating the modulation of postsynaptic serotonin receptors.2 To explore the moderate effect of genes on LPE, studies have attempted to uncover whether there is an association between LPE and the SLC6A4 gene. Zuccarello et al.4 reported that no significant differences were found in the frequency of 5-HTTLPR gene polymorphisms in LPE patients and controls. In contrast, a significant association between LPE and the 5-HTTLPR short (S) allele and the SS genotype has been reported.5 However, this study was criticized because the sample population deviated from HWE.9 In the current study, we explored whether polymorphisms in the 3’ UTR, 5’ UTR and the exons of SLC6A4 were associated with LPE. The results of our study showed that polymorphisms in the UTRs and the exons were not significantly associated with LPE in the Han population (P > 0.05). However, PE is a complex sexual dysfunction, and its moderate genetic effect cannot be explained by a single gene. For example, in the Han population, Luo et al.10 explored whether 5-HT2C receptor gene polymorphism in LPE influenced IELT in men with LPE. To the best of our knowledge, this is the first study to test the association between LPE and SNPs or SNVs in the SLC6A4 gene. In the sample population, no significant association was found between LPE and polymorphisms in the SLC6A4 gene. Further investigation in this field is needed.

AUTHOR CONTRIBUTIONS

DWP, JJG, YYH, and XSZ designed the study. DWP, YYH, DDT, PG, CL, WQL, XMD, JM, YZ, and HG acquired the data. DWP, JJG, and XSZ performed the statistical analysis and wrote the paper. All authors read and approved the final manuscript.

COMPETING INTERESTS

The authors declare no competing interests.
Table 1

SNVs in all exons in LPE patients and controls

  10 in total

1.  Association between polymorphisms in the serotonin 2C receptor gene and premature ejaculation in Han Chinese subjects.

Authors:  Shunwen Luo; Yiping Lu; Feng Wang; Zhiyuan Xie; Xiaoke Huang; Qiang Dong; Sixiao Zhang
Journal:  Urol Int       Date:  2010-05-06       Impact factor: 2.089

Review 2.  Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis.

Authors:  M D Waldinger; A H Zwinderman; D H Schweitzer; B Olivier
Journal:  Int J Impot Res       Date:  2004-08       Impact factor: 2.896

3.  Hardy Weinberg equilibrium in genetic PE research remains critical to avoid misinterpretation.

Authors:  Marcel D Waldinger; Paddy K C Janssen; Dave H Schweitzer
Journal:  Asian J Androl       Date:  2009-05-25       Impact factor: 3.285

4.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

Authors:  Xian-Zhang Hu; Robert H Lipsky; Guanshan Zhu; Longina A Akhtar; Julie Taubman; Benjamin D Greenberg; Ke Xu; Paul D Arnold; Margaret A Richter; James L Kennedy; Dennis L Murphy; David Goldman
Journal:  Am J Hum Genet       Date:  2006-03-28       Impact factor: 11.025

5.  No difference in 5-HTTLPR and Stin2 polymorphisms frequency between premature ejaculation patients and controls.

Authors:  Daniela Zuccarello; Marco Ghezzi; Manuel Pengo; Monica Forzan; Anna Chiara Frigo; Alberto Ferlin; Carlo Foresta
Journal:  J Sex Med       Date:  2012-04-10       Impact factor: 3.802

Review 6.  Serotonin and premature ejaculation: from physiology to patient management.

Authors:  François Giuliano; Pierre Clément
Journal:  Eur Urol       Date:  2006-06-19       Impact factor: 20.096

7.  Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype.

Authors:  N Ozaki; D Goldman; W H Kaye; K Plotnicov; B D Greenberg; J Lappalainen; G Rudnick; D L Murphy
Journal:  Mol Psychiatry       Date:  2003-11       Impact factor: 15.992

8.  Possible association of the 5-HTTLPR serotonin transporter promoter gene polymorphism with premature ejaculation in a Turkish population.

Authors:  Emin Ozbek; Ali I Tasci; Volkan Tugcu; Yusuf O Ilbey; Abdulmuttalip Simsek; Levent Ozcan; Emre C Polat; Vedat Koksal
Journal:  Asian J Androl       Date:  2009-03-02       Impact factor: 3.285

9.  Organization of the human serotonin transporter gene.

Authors:  K P Lesch; U Balling; J Gross; K Strauss; B L Wolozin; D L Murphy; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 10.  An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE).

Authors:  Stanley E Althof; Chris G McMahon; Marcel D Waldinger; Ege Can Serefoglu; Alan W Shindel; P Ganesan Adaikan; Edgardo Becher; John Dean; Francois Giuliano; Wayne Jg Hellstrom; Annamaria Giraldi; Sidney Glina; Luca Incrocci; Emmanuele Jannini; Marita McCabe; Sharon Parish; David Rowland; R Taylor Segraves; Ira Sharlip; Luiz Otavio Torres
Journal:  Sex Med       Date:  2014-06       Impact factor: 2.491

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.